405 related articles for article (PubMed ID: 17225991)
1. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.
Güzey C; Scordo MG; Spina E; Landsem VM; Spigset O
Eur J Clin Pharmacol; 2007 Mar; 63(3):233-41. PubMed ID: 17225991
[TBL] [Abstract][Full Text] [Related]
2. Allele and genotype frequencies of serotonin and dopamine transporter and receptor polymorphisms in a Norwegian population.
Güzey C; Lopez-Rodriguez R; Myhre R; Spigset O
Genet Test Mol Biomarkers; 2011; 15(7-8):557-63. PubMed ID: 21453053
[TBL] [Abstract][Full Text] [Related]
3. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
[TBL] [Abstract][Full Text] [Related]
4. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
Gunes A; Scordo MG; Jaanson P; Dahl ML
Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gassó P; Catalan R; Mateos JJ; Lomeña F; Parellada E
Schizophr Res; 2007 Feb; 90(1-3):115-22. PubMed ID: 17150335
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.
Hedenmalm K; Güzey C; Dahl ML; Yue QY; Spigset O
J Clin Psychopharmacol; 2006 Apr; 26(2):192-7. PubMed ID: 16633151
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
Tybura P; Trześniowska-Drukała B; Bienkowski P; Beszlej A; Frydecka D; Mierzejewski P; Samochowiec A; Grzywacz A; Samochowiec J
Psychiatry Res; 2014 Oct; 219(2):261-7. PubMed ID: 24930580
[TBL] [Abstract][Full Text] [Related]
8. Radioligand binding to brain dopamine and serotonin receptors and transporters in Parkinson's disease: relation to gene polymorphisms.
Güzey C; Allard P; Brännström T; Spigset O
Int J Neurosci; 2012 Mar; 122(3):124-32. PubMed ID: 22004534
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.
Gunes A; Dahl ML; Spina E; Scordo MG
Eur J Clin Pharmacol; 2008 May; 64(5):477-82. PubMed ID: 18205001
[TBL] [Abstract][Full Text] [Related]
10. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
[TBL] [Abstract][Full Text] [Related]
11. Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia.
Xu M; Xing Q; Li S; Zheng Y; Wu S; Gao R; Yu L; Guo T; Yang Y; Liu J; Zhang A; Zhao X; He G; Zhou J; Wang L; Xuan J; Du J; Li X; Feng G; Lin Z; Xu Y; St Clair D; Lin Z; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1026-32. PubMed ID: 20580759
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes.
Gassó P; Mas S; Crescenti A; Alvarez S; Parramon G; Garcia-Rizo C; Parellada E; Bernardo M; Lafuente A
Psychiatry Res; 2010 Jan; 175(1-2):173-5. PubMed ID: 19892410
[TBL] [Abstract][Full Text] [Related]
13. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
Alladi CG; RajKumar RP; Adithan S; Marie-Claire C; Bellivier F; Shewade DG
Fundam Clin Pharmacol; 2019 Jun; 33(3):355-364. PubMed ID: 30332506
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
15. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J
Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
17. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
[TBL] [Abstract][Full Text] [Related]
18. Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians.
Schosser A; Fuchs K; Scharl T; Schloegelhofer M; Kindler J; Mossaheb N; Kaufmann RM; Leisch F; Kasper S; Sieghart W; Aschauer HN
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):417-24. PubMed ID: 20218802
[TBL] [Abstract][Full Text] [Related]
19. Association of VNTR polymorphisms in DRD4, 5-HTT and DAT1 genes with obesity.
Uzun M; Saglar E; Kucukyildirim S; Erdem B; Unlu H; Mergen H
Arch Physiol Biochem; 2015 May; 121(2):75-9. PubMed ID: 25687785
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S; Gassó P; Lafuente A; Bioque M; Lobo A; Gonzàlez-Pinto A; Olmeda MS; Corripio I; Llerena A; Cabrera B; Saiz-Ruiz J; Bernardo M;
Pharmacogenomics J; 2016 Oct; 16(5):439-45. PubMed ID: 27272046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
